Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Johns

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
AAPS Pharmsci|December 14, 2001
Genomic structure of proton-coupled oligopeptide transporter hPEPT1 and pH-sensing regulatory splice variantA Urtti, S J Johns, W Sadée
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|January 1, 1996
An introductory course in computation molecular biology: rationale, history, observations, and course descriptionS J Johns, S M Thompson, A K Dunker
Proteins|April 1, 1992
Use of conditional probabilities for determining relationships between amino acid sequence and protein secondary structureG E Arnold, A K Dunker, S J Johns, et al.
Biochemistry|May 2, 2001
Arginine 454 and lysine 370 are essential for the anion specificity of the organic anion transporter, rOAT3B Feng, M J Dresser, Y Shu, et al.
Clinical Pharmacology and Therapeutics|October 23, 2012
The UCSF-FDA TransPortal: a public drug transporter databaseK M Morrissey, C C Wen, S J Johns, et al.
The Pharmacogenomics Journal|March 2, 2005
Functional analysis of genetic variants in the human concentrative nucleoside transporter 3 (CNT3; SLC28A3)I Badagnani, W Chan, R A Castro, et al.
The Pharmacogenomics Journal|January 11, 2012
Genetic and epigenetic regulation of the organic cation transporter 3, SLC22A3L Chen, C Hong, E C Chen, et al.
Clinical Pharmacology and Therapeutics|March 4, 2011
Functional characterization of liver enhancers that regulate drug-associated transportersM J Kim, P Skewes-Cox, H Fukushima, et al.
Clinical Pharmacology and Therapeutics|September 30, 2011
A common 5'-UTR variant in MATE2-K is associated with poor response to metforminJ H Choi, S W Yee, A H Ramirez, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
AAPS Pharmsci|December 14, 2001
Genomic structure of proton-coupled oligopeptide transporter hPEPT1 and pH-sensing regulatory splice variantA Urtti, S J Johns, W Sadée
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|January 1, 1996
An introductory course in computation molecular biology: rationale, history, observations, and course descriptionS J Johns, S M Thompson, A K Dunker
Proteins|April 1, 1992
Use of conditional probabilities for determining relationships between amino acid sequence and protein secondary structureG E Arnold, A K Dunker, S J Johns, et al.
Biochemistry|May 2, 2001
Arginine 454 and lysine 370 are essential for the anion specificity of the organic anion transporter, rOAT3B Feng, M J Dresser, Y Shu, et al.
Clinical Pharmacology and Therapeutics|October 23, 2012
The UCSF-FDA TransPortal: a public drug transporter databaseK M Morrissey, C C Wen, S J Johns, et al.
The Pharmacogenomics Journal|March 2, 2005
Functional analysis of genetic variants in the human concentrative nucleoside transporter 3 (CNT3; SLC28A3)I Badagnani, W Chan, R A Castro, et al.
The Pharmacogenomics Journal|January 11, 2012
Genetic and epigenetic regulation of the organic cation transporter 3, SLC22A3L Chen, C Hong, E C Chen, et al.
Clinical Pharmacology and Therapeutics|March 4, 2011
Functional characterization of liver enhancers that regulate drug-associated transportersM J Kim, P Skewes-Cox, H Fukushima, et al.
Clinical Pharmacology and Therapeutics|September 30, 2011
A common 5'-UTR variant in MATE2-K is associated with poor response to metforminJ H Choi, S W Yee, A H Ramirez, et al.
Pageof 1